GMP and GCP Inspectors work closely with MHRA Clinical Trials and regularly provide support to help answer a wide range of stakeholder queries which relate to the manufacture, import, labelling, licencing requirements and general handling of Investigational Medicinal Products (IMPs).

The previously published MHRA ‘frequently asked questions’ blog has been updated. You can read more HERE.

Please follow and like us:
Pin Share